Founded in 1967, Quest Diagnostics (DGX) is the leading global provider of diagnostic information services. Headquartered in Madison, New Jersey, the company has a team of 43,000 employees that operate 2,200 patient service centres across the country. Annually, Quest serves one in three adult Americans and half the hospitals and physicians in the USA. Quest Diagnostics delivers diagnostic testing services for neurological disorders, cardiovascular disease, infectious diseases and cancer. With an annual revenue of $7.5 billion the company is included to the S&P 500 index. The Quest Diagnostics share price (DGX) is set and traded on the New York Stock Exchange (NYSE).
Latest shares articles
Forex CFDs: Understanding currency forwards vs spot markets
Spot or forward? These two forex markets behave differently, and now you can trade both with us as forex CFDs. Here’s how they work, and what sets them apart.
14:48, 31 July 2025
Crypto CFDs: Popular cryptocurrencies for trading
Discover which cryptocurrencies are trending for CFD trading in 2025 – from bitcoin to newly listed coins like SUI and PEPE.
10:46, 31 July 2025
Trading the Nasdaq 100 Amidst Big Tech Earnings
Microsoft and Meta notably impressed powering the tech-heavy index higher in the futures market, but it’s two down and two more to go as both Apple and Amazon are next.
07:04, 31 July 2025
Ripple price prediction: Third-party price target
Ripple, launched in 2012 with the XRP Ledger, aims to make cross-border payments faster and cheaper using its native token, XRP. Backed by financial institutions and a strong market presence, it remains a major crypto asset by market cap.
14:34, 30 July 2025
Ratings and Reviews
Ratings and Reviews
